MedTrace Logo

Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis

NCT03793270 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2019-01-04

No results posted yet for this study

Summary

Rheumatoid Arthritis (RA):

RA is a chronic inflammatory autoimmune disease that primarily affects the small joints, eventually leading to bone erosion and an inability to move (1). Several immune cells participate in the pathogenesis of RA. One of those cells is B cell.

Conditions

Interventions

DIAGNOSTIC_TEST

for patients and healthy donors

1. Detection of (CD19, CD24, CD38 \& CD27) markers in peripheral blood samples by Flow Cytometry 2. Determine the serum level of IL 10 using ELISA plate

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2019-08-20
Completion
2020-08-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793270 on ClinicalTrials.gov